Cargando…

Polymorphic variants of SLCO1B1 in neonatal hyperbilirubinemia in China

BACKGROUND: To evaluate the association between the genetic polymorphism of the solute carrier organic anion transporter family member 1B1 (SLCO1B1, also known as organic anion transport polypeptide C) and hyperbilirubinemia in Chinese neonates. METHODS: 183 infants with hyperbilirubinemia and 192 c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jiebo, Long, Jun, Zhang, Shaofang, Fang, Xiaoyan, Luo, Yuyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750622/ https://www.ncbi.nlm.nih.gov/pubmed/24090270 http://dx.doi.org/10.1186/1824-7288-39-49

Ejemplares similares

SLCO1B1 c.388A > G variant incidence and the severity of hyperbilirubinemia in Indonesian neonates
por: Amandito, Radhian, et al.
Publicado: (2019)

Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population
por: Atasilp, Chalirmporn, et al.
Publicado: (2022)

Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia
por: Bai, Jie, et al.
Publicado: (2019)

SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria
por: Sortica, Vinicius A, et al.
Publicado: (2017)

Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers
por: Song, Gonjin, et al.
Publicado: (2021)

SLCO1B1 Polymorphisms and Statin-Induced Myopathy
por: Stewart, Alison
Publicado: (2013)

Neonatal hyperbilirubinemia
por: Ben, Matteo Dal, et al.
Publicado: (2014)

SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
por: Rattanacheeworn, Punyabhorn, et al.
Publicado: (2020)

Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis
por: Ninomiya, Kohei, et al.
Publicado: (2022)

Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan
por: Weng, Yi-Hao, et al.
Publicado: (2016)

Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis
por: Yu, Zibi, et al.
Publicado: (2015)

An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure
por: Vandell, A G, et al.
Publicado: (2018)

Effects of SLCO1B1 Genetic Variant on Metabolite Profile in Participants on Simvastatin Treatment
por: Fernandes Silva, Lilian, et al.
Publicado: (2022)

A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics
por: Lehtisalo, Minna, et al.
Publicado: (2022)

The role of UGT1A1 (c.-3279 T > G) gene polymorphisms in neonatal hyperbilirubinemia susceptibility
por: Li, Zijin, et al.
Publicado: (2020)

Neurobehavior of term neonates with neonatal hyperbilirubinemia
por: Babu, Thirunavukkarasu Arun, et al.
Publicado: (2013)

Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban
por: Han, Ji Min, et al.
Publicado: (2023)

UGT1A1 variants in Chinese Uighur and Han newborns and its correlation with neonatal hyperbilirubinemia
por: Yang, Hui, et al.
Publicado: (2022)

Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
por: Taylor, Zachary L., et al.
Publicado: (2021)

SLCO1B1: Application and Limitations of Deep Mutational Scanning for Genomic Missense Variant Function
por: Zhang, Lingxin, et al.
Publicado: (2021)

Antioxidant vitamins and hyperbilirubinemia in neonates
por: Abdul-Razzak, Khalid K., et al.
Publicado: (2007)

Association Study of SLCO1B3 and ABCC3 Genetic Variants in Gallstone Disease
por: Banach, Bolesław, et al.
Publicado: (2022)

SLCO1B1 Polymorphism is not associated with Risk of Statin-Induced Myalgia/Myopathy in a Czech Population
por: Hubáček, Jaroslav A., et al.
Publicado: (2015)

Frequencies of single-nucleotide polymorphisms and haplotypes of the SLCO1B1 gene in selected populations of the western balkans
por: Grapci, A Daka, et al.
Publicado: (2015)

The frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemia
por: Sychev, Dmitrij Alekseevitch, et al.
Publicado: (2016)

Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population
por: Na nakorn, Chalitpon, et al.
Publicado: (2020)

SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability
por: Zubiaur, Pablo, et al.
Publicado: (2021)

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine
por: Calleja, Sofía, et al.
Publicado: (2023)

SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril) -Induced Cough: a Pharmacogenetic Study
por: Luo, Jian-Quan, et al.
Publicado: (2015)

Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant
por: Merkel, Melissa, et al.
Publicado: (2021)

Influence of SLCO1B1 and CYP2C8 gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers
por: Aquilante, Christina L, et al.
Publicado: (2008)

Challenges of phototherapy for neonatal hyperbilirubinemia (Review)
por: Wang, Juan, et al.
Publicado: (2021)

Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder
por: Häkkinen, Katja, et al.
Publicado: (2023)

Impact of SLCO1B3 Polymorphisms on Clinical Outcomes in Lung Allograft Recipients Receiving Mycophenolic Acid
por: Tague, Laneshia K., et al.
Publicado: (2019)

The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose–corrected trough concentration in the early period after liver transplantation
por: Wu, Yi, et al.
Publicado: (2021)

Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with Familial Hypercholesterolemia: a case report
por: Dagli-Hernandez, Carolina, et al.
Publicado: (2021)

SLCO1B1 genetic variation and hormone therapy in menopausal women
por: Moyer, Ann M., et al.
Publicado: (2018)

Associations of the SLCO1B1 Polymorphisms With Hepatic Function, Baseline Lipid Levels, and Lipid-lowering Response to Simvastatin in Patients With Hyperlipidemia
por: Wu, Xiangyu, et al.
Publicado: (2018)

Interaction Effects of AFB1 and MC-LR Co-exposure with Polymorphism of Metabolic Genes on Liver Damage: focusing on SLCO1B1 and GSTP1
por: Yang, Xiaohong, et al.
Publicado: (2017)

Ethylmethylhydroxypyridine Succinate Is an Inhibitor but Not a Substrate of ABCB1 and SLCO1B1
por: Shchulkin, Aleksey V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bl40e2t9rh04p7b7garpsu12us